VR17-04

• Bioactivity:

  VR17-04, a metabolite of Enisamium, inhibits the incorporation of GTP and UTP during RNA synthesis. Its mechanism of action was elucidated through docking and molecular dynamics simulations. These findings suggest that VR17-04 could serve as a potential antiviral strategy for managing COVID-19.

• Smiles:

  O=C (NCC=1C=CC=CC1) C2=CC=[N+] (C=C2O) C

• Molecular Formula:

  C14H15N2O2

• Molecular Weight:

  243.28

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2417925-64-3